Hormone Therapy Before Radical Prostatectomy Offers No Benefit
For patients with prostate cancer who are to undergo radical prostatectomy, 3 months of neoadjuvant hormonal therapy before surgery has no benefit and is not
לקבלת קוד אימות לנייד ולמייל, יש למלא את כתובת המייל ואת מספר הטלפון שלך
For patients with prostate cancer who are to undergo radical prostatectomy, 3 months of neoadjuvant hormonal therapy before surgery has no benefit and is not
The polycomb group protein ‘enhancer of zeste’ homolog 2 (EZH2) is overexpressed in hormone-refractory metastatic prostate cancer, and may be involved in cancer progression along
Leflunomide reversed chronic renal allograft dysfunction in a prospective pilot study reported in the October issue of the American Journal of Transplantation. “Leflunomide is an
The U.S. FDA has approved a supplemental new drug application for dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an
Laurie Barclay, MD Oct. 8, 2002 Most men with prostate cancer want ready access to prostate-specific antigen (PSA) screening, according to the results of
NEW YORK (Reuters Health) Oct 08 – More than 65% of African-American patients with overt type 2 diabetic nephropathy have at least one diabetic sibling
By Steven Reinberg NEW YORK (Reuters Health) Oct 08 – For patients with prostate cancer who are to undergo radical prostatectomy, 3 months of neoadjuvant
Laurie Barclay, MD Oct. 9, 2002 Editor’s Note: The Office of the Inspector General (OIG) is reining in the pharmaceutical industry with respect to
Laurie Barclay, MD Oct. 4, 2002 Ureteroscopy with holmium laser lithotripsy is a safe and effective approach to the treatment of ureteral stones during
NEW YORK (Reuters Health) Oct 04 – More than a third of peritoneal dialysis (PD) patients are not compliant with the erythropoietin (EPO) regimen they
NEW YORK (Reuters Health) Oct 04 – Findings from a new study indicate that there is a significant lack of standardization among US laboratories in
In patients with prostate cancer that has spread to bone, treatment with zoledronic acid reduces the risk of skeletal events, according to a report published
Comparison between programs of aggressive, and less aggressive, prostate cancer screening and treatment in two American states shows that more intensive screening and treatment with
By Jacqueline Stenson SAN DIEGO, California (Reuters Health) Sept 30 – Men with Chlamydia trachomatis infection appear to have a reduced risk of prostate cancer,
By Steven Reinberg NEW YORK (Reuters Health) Sept 30 – Although a belief that shoe size reflects penile length is widespread, there appears to be
בכתבתה של תמרה טראובמן מעתון הארץ מציגה הכתכת סקירה של תוצאות מחקר המתפרסם לאחרונה בניו-אינגלנד, וכן מציגה חוות דעת של מס’ רופאים בארץ לגבי הסוגייה.
Surgical stent implantation into the prostatic urethra may help predict the risk of incontinence following transurethral resection of the prostate gland (TURP) in high risk
Bayer and GlaxoSmithKline (GSK) announced that following regulatory approval, they will market vardenafil, an investigational treatment for erectile dysfunction (ED), under the global trade name
The selective serotonin reuptake inhibitor (SSRI) fluvoxamine offered pain relief in patients with prostatodynia, according to the results of a randomized controlled trial reported in
אירגון ה- NICE הבריטי הפיק הנחיות חדשות להשגת שיפור תוצאות בסוגי סרטן אורולוגי. מטרת ההנחיות היא לשפר תקשורת ותיאום בין אירגונים ורופאים העוסקים בטיפול בסרטן אורולוגי. להנחיות
ניתן להשתמש בחצי המקלדת ובמקש Esc לפתיחה וסגירה.